null - FindTrial

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004552-19-FR

Enrollment

Unknown

Registered

2011-11-17

Start date

2012-02-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10022002 Term: Influenza A virus infection System Organ Class: 10021881 - Infections and infestations

Interventions

Trade Name: GUTRON Pharmaceutical Form: Tablet INN or Proposed INN: MIDODRINE HYDROCHLORIDE CAS Number: 3092-17-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 161 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactClinical Trials Information

Hospices Civils de Lyon

valerie.plattner@chu-lyon.fr472 115 213+33

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026